针对性地使白血病T细胞对SIRT1激动剂SRT-172020的抗癌药物的敏感化
Donika Ivanova1, Dessislava Lazarova2, Zhivko Zhelev3,4
1Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria.
Anticancer research
|January 30, 2026
概括
SRT-1720通过诱导白血病细胞的氧化应激来增强化疗,同时保护正常细胞. 这一策略显示了在T细胞急性淋巴细胞白血病 (T-ALL) 治疗中降低毒性的潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 沉默信息调节器1 (SIRT1) 在癌症中起着双重作用,作为瘤抑制剂或促进剂.
- 像SRT-1720这样的小分子SIRT1激活剂已经显示出抗癌潜力,但它们在白血病中的机制尚不清楚.
研究的目的:
- 研究SRT-1720对白血病和正常淋巴细胞的氧化还原状态和活力的影响.
- 为了确定SRT-1720是否使白血病细胞对常规抗癌药物敏感.
主要方法:
- 评估了SRT-1720与抗癌药物的协同作用,添加剂或对抗作用.
- 测量了细胞活力,增殖,亡,活性氧物种 (ROS) 和蛋白质碳基产物.
主要成果:
- SRT-1720与多种化疗剂 (例如,巴拉塞尔蒂布,博尔特佐米布,西斯普拉丁) 协同作用,对抗白血病淋巴细胞.
- SRT-1720增加了对某些药物的正常淋巴细胞耐受性,并减少了多克索鲁比诱导的氧化应激.
- 白血病细胞中的协同性细胞毒性涉及ROS过量产生和亡诱导,与对正常细胞的影响不同.
结论:
- 在白血病细胞中,SRT-1720通过SIRT1独立的途径诱导氧化应激和亡.
- 通过一种SIRT1依赖的途径,SRT-1720可以增强正常淋巴细胞中的抗氧化防御.
- 作为T-ALL的辅助疗法,SRT-1720显示出有前途,可能允许减少化疗剂量和毒性.
相关概念视频
01:25Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
984
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
984
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.7K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.7K
01:26Targets for Drug Action: Overview
10.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.3K
01:30Adrenergic Agonists: Therapeutic Uses
1.9K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.9K
01:24Glucagon-like Receptor Agonists
959
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
959